Abstract
The precise identification of gene fusions is crucial for cancer diagnosis and therapeutic decision-making. Long-read transcriptome sequencing provides distinct advantages over short-read technologies by capturing full-length fusion gene structures. However, fully harnessing long-read data for cancer research necessitates advanced computational approaches. In this study, we present GFHunter, a novel computational framework designed for efficient and accurate gene fusion detection. Benchmarking on both simulated and real long-read transcriptome datasets from non-tumor and cancer cell lines demonstrates that GFHunter accurately detects gene fusions with high sensitivity and significantly reduces false positives. Additionally, GFHunter runs 2-3 times faster and requires only 16%-50% of the memory compared to state-of-the-art tools. Notably, GFHunter uniquely identifies two known cancer-related fusions in HCT-116 and SKBR-3 cancer cell lines. These results highlight GFHunter’s potential as a powerful tool for advancing precision oncology and molecular diagnostics.
Full text
1,163 characters
· extracted from
oa-doi-fallback
· click to expand
Abstract
The precise identification of gene fusions is crucial for cancer diagnosis and therapeutic decision-making. Long-read transcriptome sequencing provides distinct advantages over short-read technologies by capturing full-length fusion gene structures. However, fully harnessing long-read data for cancer research necessitates advanced computational approaches. In this study, we present GFHunter, a novel computational framework designed for efficient and accurate gene fusion detection. Benchmarking on both simulated and real long-read transcriptome datasets from non-tumor and cancer cell lines demonstrates that GFHunter accurately detects gene fusions with high sensitivity and significantly reduces false positives. Additionally, GFHunter runs 2-3 times faster and requires only 16%-50% of the memory compared to state-of-the-art tools. Notably, GFHunter uniquely identifies two known cancer-related fusions in HCT-116 and SKBR-3 cancer cell lines. These results highlight GFHunter’s potential as a powerful tool for advancing precision oncology and molecular diagnostics.
Competing Interest Statement
The authors have declared no competing interest.
Text is read by the "Ask this paper" AI Q&A widget below.
Extraction quality varies by source — PMC NXML preserves structure
cleanly, OA-HTML may include some navigation residue, and OA-PDF can
have broken hyphenation. The publisher copy
(via DOI)
is the canonical version.